RE: [External email] Sad news about Dr. Ludden
I agree. While I only met Tom in person a few times we interacted quite a bit
in my early days of PMx and NONMEM. Tom was immensely clever, kind,
unassuming, understanding and supportive. A pleasure to chat with and to learn
from.
Steve
Stephen Duffull
Senior Scientific Advisor, Certara Drug Development Solutions
[email protected]<mailto:[email protected]>
Dunedin, Aotearoa New Zealand (NZ Time Zone: UTC +12)
http://www.certara.com/
[cid:[email protected]]
Quoted reply history
From: [email protected] <[email protected]> On Behalf Of
Paul Hutson
Sent: Sunday, August 4, 2024 3:32 AM
To: Ekaterina Gibiansky <[email protected]>; Diane Mould
<[email protected]>; Riley, Steve <[email protected]>;
[email protected]
Subject: RE: [External email][NMusers] Sad news about Dr. Ludden
Some people who received this message don't often get email from
[email protected]<mailto:[email protected]>. Learn why this is
https://aka.ms/LearnAboutSenderIdentification
CAUTION: This email originated from outside of Certara. Do not click links or
open attachments unless you recognize the sender and know the content is safe.
What a giant. I always appreciated his kindness in responding to my naiive
questions about coding NONMEM.
Paul R. Hutson, PharmD, BCOP
Professor (CHS)
UW School of Pharmacy
Director, UW Madison Transdisciplinary Center for Research in Psychoactive
https://www.research.pharmacy.wisc.edu/tcrps
Faculty Leader, Paul P. Carbone Comprehensive Cancer Center Cancer Pharmacology
https://cancer.wisc.edu/research/resources/ddc/cancer-pharmacology/
T: 608.263.2496
[email protected]<mailto:[email protected]>
From: [email protected]<mailto:[email protected]>
<[email protected]<mailto:[email protected]>> On Behalf
Of Ekaterina Gibiansky
Sent: Friday, August 2, 2024 3:19 PM
To: Diane Mould <[email protected]<mailto:[email protected]>>; Riley,
Steve <[email protected]<mailto:[email protected]>>;
[email protected]<mailto:[email protected]>
Subject: Re: [External email][NMusers] Sad news about Dr. Ludden
I second everything Steve, and Mark, and Diane said. All of us who were blessed
to work alongside him will forever remember him with fondness and gratitude.
And let's not forget that he was the only one who Stuart Beal trusted to take
care of NONMEM and bring it forward into 21st century.
Katya
On 8/2/2024 3:55 PM, Diane Mould wrote:
Dear All
I am very saddened to hear this news. Tom Ludden was one of the nicest and
smartest people that I have ever known. He was a gentle giant in our field and
I will miss him.
Best
Diane
From: [email protected]<mailto:[email protected]>
<[email protected]><mailto:[email protected]> On Behalf
Of Riley, Steve
Sent: Friday, August 2, 2024 2:41 PM
To: [email protected]<mailto:[email protected]>
Subject: [External email][NMusers] Sad news about Dr. Ludden
CAUTION: This email originated from outside the organization. Do not click
links or open attachments unless you recognize the sender and know the content
is safe.
Dear NM-Users,
Regrettably, I am writing to let you know that Dr. Ludden passed away Tuesday
evening, 30JUL2024.
I was able to get there over the weekend prior to visit him and his family.
During his wakeful moments we had some good scientific discussions.
We talked a lot about NONMEM and how its functionality and utility has expanded
since he retired. He was pleased to hear about the changes.
He was surrounded by family for the days leading up to the end. They were all
appreciative that I was able to get there and tell him (and them) how much he
meant to all of us and the impact he had on our careers.
I think memories of Dr. Ludden were characterized perfectly by Marc Gastonguay,
"I am forever grateful for the positive impact that Tom had on my life and
career, not to mention the tremendous, although often underappreciated,
contributions he made to the disciplines of clinical pharmacology and
pharmacometrics. His humble brilliance will be missed and fondly remembered."
Steve Riley
This message (including any attachments) may contain confidential, proprietary,
privileged and/or private information. The information is intended to be for
the use of the individual or entity designated above. If you are not the
intended recipient of this message, please notify the sender immediately, and
delete the message and any attachments. Any disclosure, reproduction,
distribution or other use of this message or any attachments by an individual
or entity other than the intended recipient is prohibited.